Osteogenesis imperfecta at the beginning of bone and joint decade

Croatian Medical Journal

Volumn 42, Issue 4, 2001, Pages 393-415

  Primorac, D ^a   Rowe, D W ^a   Mottes, M ^a   Barisic I ^a   Anticevic D ^a   Mirandola, S ^a   Gomez Lira, M ^a   Kalajzic I ^a   Kusec V ^a   Glorieux, F H ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

Collagen; Dentinogenesis imperfecta; Gene therapy; Genetics; Mutation; Osteogenesis imperfecta; Syndrome

Indexed keywords

ANABOLIC AGENT; CALCITONIN; COLLAGEN TYPE 1; FLUORIDE; MAGNESIUM OXIDE; PAMIDRONIC ACID; PHOSPHONIC ACID DERIVATIVE;

BONE MATRIX; COLLAGEN SYNTHESIS; DISEASE CLASSIFICATION; FRACTURE; GENE MUTATION; GENE THERAPY; GENETIC DISORDER; GENETIC LINKAGE; GENOTYPE; HUMAN; MORPHOMETRICS; OSTEOGENESIS IMPERFECTA; PHENOTYPE; REVIEW;

NON-PROGRAMMATIC;

ANIMALS; CHILD; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; GENE THERAPY; HUMANS; LINKAGE (GENETICS); MICE; MUTATION; OSTEOGENESIS IMPERFECTA; PLATYBASIA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SCOLIOSIS;

EID: 0034865790     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (198)

1. Zur Kenntnis der Osteogenesis imperfecta congenita und tarda, Mitteilungen Grenzgebiete
2. Consequences of an osteogenesis imperfecta diagnosis for survival and ambulation
3. Osteogenesis imperfecta. Radiographic classification, natural history, and treatment of spinal deformities
4. Rehabilitation approaches to children with osteogenesis imperfecta: A ten-year experience
5. Genetic heterogeneity in osteogenesis imperfecta
6. Osteogenesis imperfecta nosology and genetics
7. Type V osteogenesis imperfecta: A new form of brittle bone disease
8. Heterogeneity in osteogenesis imperfecta
9. Osteogenesis imperfecta
10. Osteogenesis imperfecta: From phenotype to genotype and back again
11. Osteogenesis imperfecta: A clinical study of the first ten years of life
12. Osteogenesis imperfecta: Clinical, cephalometric, and biochemical investigations of OI types I, III, and IV
13. Osteogenesis imperfecta and hearing loss
14. Hearing loss (in nonoperated ears) in relation to age in osteogenesis imperfecta type I
15. Hearing loss in children with osteogenesis imperfecta
16. Classification of osteogenesis imperfecta by dental characteristics
17. Mild forms of dentinogenesis imperfecta in association with osteogenesis imperfecta as characterized by light and transmission electron microscopy
18. Scanning electron microscopy of teeth in osteogenesis imperfecta type I
19. Dental findings in osteogenesis imperfecta: II. Dysplastic and other developmental defects
20. Recent findings in classification of osteogenesis imperfecta by means of existing dental symptoms
21. Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta
22. Hemostatic studies in osteogenesis imperfecta
23. Cardiovascular abnormalities in osteogenesis imperfecta
24. Osteogenesis imperfecta: Profiles of motor development as assessed by a postal questionnaire
25. Osteogenesis imperfecta in childhood: Impairment and disability
26. Osteogenesis imperfecta in childhood: Prognosis for walking
27. Psychosocial aspects of osteogenesis imperfecta: An update
28. Causes of death in osteogenesis imperfecta
29. Type I osteogenesis imperfecta: Diagnostic difficulties
30. Perinatal lethal osteogenesis imperfecta
31. Parentalmosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV
32. Prenatal diagnosis of collagen disorders by direct biochemical analysis of chorionic villus biopsies
33. Fetal imaging in the skeletal dysplasias: Overview and experience
34. Antenatal diagnosis of lethal skeletal dysplasias
35. Perinatal lethal osteogenesis imperfecta (OI type II): A biochemically heterogenous disorder usually due to new mutations in the genes for the type I collagen
36. Osteogenesis imperfecta type II: Microvascular changes in the CNS
37. Abnormalities in the central nervous system development in osteogenesis imperfecta type II
38. Osteogenesis imperfecta type II. Delineation of phenotype with reference to genetic heterogeneity
39. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta
40. Osteogenesis imperfecta
41. Evaluation of oral problems in an osteogenesis imperfecta population
42. Osteogenesis imperfecta with unusual skeletal lesions: Report for three families
43. Gastrointestinal problems in patients who have type III osteogenesis imperfecta
44. Hypercalciuria in osteogenesis imperfecta: A follow-up stud to assess renal effects
45. The prognosis for walking in osteogenesis imperfecta
46. Osteogenesis imperfecta in childhood: Treatment strategies
47. Vertebral body shape as a predictor of spinal deformity in osteogenesis imperfecta
48. Spine deformity and pulmonary compromise in osteogenesis imperfecta
49. Spinal complications in osteogenesis imperfecta: 47 patients 1-16 years of age
50. Craniocervical abnormalities in osteogenesis imperfecta: Genetic and molecular correlation
51. Communicating hydrocephalus, basilar invagination and other neurological features in osteogenesis imperfecta
52. Osteogenesis imperfecta: Rehabilitation and prospects for gene therapy
53. Anthropometry of patients with osteogenesis imperfecta
54. Life expectancy in osteogenesis imperfecta
55. Osteogenesis imperfecta: Mosaicism and refinement of the genotype-phenotype map in OI type III. Mutations in brief no. 242. Online
56. Non-accidental injury or brittle bones
57. Basilar impression complicating osteogenesis type IV: The clinical and neuroradiological findings in four cases
58. Type V osteogenesis imperfecta: A new form of Brittle bone disease
59. Osteogenesis imperfecta type VI: Form of Brittle bone disease with a mineralization defect
60. Rhizomelic osteogenesis imperfecta: An autosomal recessive form of brittle bone disease in a Native American community
61. The human type I collagen mutation database
62. Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta
63. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix
64. Alternative splicing in COL1A1 mRNA leads to a partial null allele and two In-frame forms with structural defects in non-lethal osteogenesis imperfecta
65. Two pregnancies after preimplantation genetic diagnosis for osteogenesis imperfecta type I and type IV
66. Canine COL1A2 mutation resulting in C-terminal truncation of pro-alpha2(I) and severe osteogenesis imperfecta
67. Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta
68. Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains
69. Osteogenesis imperfecta type I: Molecular heterogeneity for COL1A1 null alleles of type I collagen
70. Identification and characterization of human orthologues to Saccharomyces cerevisiae Upf2 protein and Upf3 protein (Caenorhabditis elegans SMG-4)
71. Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta
72. Osteogenesis imperfecta: Current concepts
73. Tracking COL1A1 RNA in osteogenesis imperfecta, splice-defective transcripts initiate transport from the gene but are retained within the SC35 domain
74. Transgenic mouse model of the mild dominant form of osteogenesis imperfecta
75. Osteogenesis imperfecta: Prospects for molecular therapeutics
76. Embryonic lethal mutation in mice induced by retrovirus insertion into the alpha 1(I) collagen gene
77. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death
78. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene
79. Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta
80. Use of the Cre/lox recombination system to develop a non-lethal knock- in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice
81. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: A model of human osteogenesis imperfecta
82. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress
83. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain
84. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering
85. The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: A survey using backscattered electron imaging
86. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta
87. Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: A review of biochemical and molecular studies completed in 129 pregnancies
88. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: Identification of common sequences of null-allele mutations
89. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders
90. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta
91. Mild dominant osteogenesis imperfecta with intrafamilial variability: The cause is a serine for glicine α1(I)901 substitution in a type I collagen gene
92. Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in the COL1A1 and COL1A2 genes
93. Three novel polymorphic sequenze variants in the type I collagen gene COL1A1, the main disease locus for Osteogenesis Imperfecta
94. Premature termination is a unifying Mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains
95. PCR-based linkage strategies for the type I collagen genes
96. A four base pair insertion polymorphism in the 3′ untranslated region of the COL1A1 gene is highly informative for null allele testing in patients with osteogenesis imperfecta type I
97. Osteogenesis imperfecta: Bone turnover, bone density, and ultrasound parameters
98. Collagen-derived markers of bone metabolism in osteogenesis imperfecta
99. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
100. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta
101. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta
102. Osteogenesis imperfecta - Current perspectives and treatment
103. Bone histomorphometry in adults with type IA osteogenesis imperfecta
104. Scoliosis associated with osteogenesis imperfecta. Results of treatment
105. Skeletal complications in osteogenesis imperfecta. A review of 153 South African patients
106. The spine in osteogenesis imperfecta
107. A three-level fracture of the axis in a patient with osteogenesis imperfecta
108. Basilar invagination in osteogenesis imperfecta and related osteochondrodysplasias: Medical and surgical management
109. Osteogenesis imperfecta as a differential diagnosis of pathologic burst fractures of the spine. A case report
110. Spondylolisthesis resulting from osteogenesis imperfecta. Report of a case
111. The spine in osteogenesis imperfecta
112. Osteogenesis imperfecta. Perspectives
113. Osteogenesis imperfecta
114. Scoliosis in osteogenesis imperfecta
115. Scoliosis in patients with osteogenesis imperfecta: A federal nation-wide cross-sectional study
116. The development of the spinal deformities in osteogenesis imperfecta
117. Osteogenesis imperfecta. An orthopaedic description and surgical review
118. The spine in osteogenesis imperfecta
119. Brace treatment for scoliosis in osteogenesis imperfecta, (im)possibilities
120. Spinal deformity, pulmonary compromise and quality of life in osteogenesis imperfecta
121. Methylmethacrylate as an adjunct in spinal instrumentation
122. Osteogenesis imperfecta: Orthopedic aspects
123. Spinal fusion in situ in osteogenesis imperfecta
124. Complications of spine surgery in children
125. Operative treatment of spine deformity in osteogenesis imperfecta
126. The spine and surgical treatment in osteogenesis imperfecta
127. Spinal deformity in osteogenesis imperfecta
128. Craniocervical abnormalities in osteogenesis imperfecta: Genetic and molecular correlation
129. Basilar impression complicating osteogenesis imperfecta: Natural history and correlation with OI type
130. Basilar impression in osteogenesis imperfecta. A report of three cases in one family
131. Osteogenesis imperfecta
132. Cervical spine disorders in infants and children
133. The operative management of basilar impression in osteogenesis imperfecta
134. Basilar impression complicating osteogenesis imperfecta type IV: The clinical and neuroradiological findings in four cases
135. Multiple osteotomies and intramedullary fixation of the radius and the ulna to correct severe deformity and improve function in osteogenesis imperfecta
136. Bilateral isolated olecranon fractures in an infant as presentation of osteogenesis imperfecta
137. Displaced fractures of the apophysis of the olecranon in children who have osteogenesis imperfecta
138. Aneurysmal bone cyst in a patient with osteogenesis imperfecta
139. Functional outcome of Sofield procedure in the upper limb in osteogenesis imperfecta
140. Telescoping intramedullary stabilisation of the lower extremities for severe osteogenesis imperfecta
141. Functional results of operating in osteogenesis imperfecta: Elongating and nonelongating rods
142. Complications of intramedullary rods in osteogenesis imperfecta: Bailey-Dubow rods versus nonelongating rods
143. Management of lower-extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: A 20-year experience
144. Complications in the use of the Bailey-Dubow extensible nail
145. Complications after treatment of patients with osteogenesis imperfecta with a Bailey-Dubow rod
146. Complications of the Bailey-Dubow elongating nail in osteogenesis imperfecta: 34 children with 110 nails
147. Experience with Bailey-Dubow rodding in children with osteogenesis imperfecta
148. The Sofield-Millar operation in osteogenesis imperfecta
149. Intramedullary rodding in osteogenesis imperfecta
150. Child abuse or osteogenesis imperfecta: How can we tell?
151. Non-accidental injury
152. Osteogenesis imperfecta: The distinction from child abuse and the recognition of a variant form
153. Temporary brittle bone disease: Association with decreased fetal movement and osteopenia
154. Metabolic and endocrine abnormalities. Osteogenesis imperfecta
155. Temporary brittle bone disease: Follow up observations of children at home
156. Transient osteoporosis and osteogenesis imperfecta. A case report
157. Transient osteoporosis of the hip associated with osteogenesis imperfecta
158. Obstruction of the colon due to protrusio acetabuli in osteogenesis imperfecta: Treatment by pelvic osteotomy
159. Aftermath of osteogenesis imperfecta: The disease in adulthood
160. Hip and knee replacement in osteogenesis imperfecta
161. Non-union of fractures in children who have osteogenesis imperfecta
162. Treatment of deformity of the lower limb in adults who have osteogenesis imperfecta
163. Osteosarcoma occurring in osteogenesis imperfecta
164. Osteogenesis imperfecta complicated by osteosarcoma
165. Hyperplastic callus and osteogenesis imperfecta
166. Hyperplasticcallus formation in both femurs in osteogenesis imperfecta
167. Hyperplastic callus formation in OI (letter)
168. MRI and CT features of hyperplastic callus in osteogenesis imperfecta tarda
169. Aggravation of skeletal deformities in osteogenesis imperfecta during puberty - Cause or coincidence?
170. Management of osteogenesis imperfecta in adolescents and adults
171. Osteogenesis imperfecta after the menopause
172. Closed intramedullary rodding for osteogenesis imperfecta
173. Early semiclosed intramedullary stabilization in osteogenesis imperfecta
174. Assessing the subtalar joint: The Broden view revisited
175. Early surgical management of severe forms of osteogenesis imperfecta
176. Percutaneous intramedullary fixation of long bone deformity in severe osteogenesis imperfecta
177. Intramedullary rodding in type III osteogenesis imperfecta
178. New approaches to treatment of osteogenesis imperfecta
179. Cyclical pamidronate therapy in children with severe osteogenesis imperfecta
180. Bisphosphonates: Mechanism of action
181. Pamidronate treatment of severe osteogenesis imperfecta in children under three years of age
182. Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway
183. Gene repair using chimeric RNA/DNA oligonucleotides
184. Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro
185. The sCYMV1 hairpin ribozyme: Targeting rules and cleavage of heterologous RNA
186. Reduction of target gene expression by a modified U1 snRNA
187. Processing of carnitine octanoyltransferase pre-mRNAs by cis and trans- splicing
188. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing
189. Inhibition of viral gene expression by human ribonuclease P.
190. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts
191. Retroviral expression in embryonic stem cells and hematopoietic stem cells
192. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse
193. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts
194. Bone marrow stromal cells as a vehicle for gene transfer
195. Osteoprogenitor cells as targets for ex vivo gene transfer
196. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta
197. Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice